EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, BCRX: Biocryst Pharma Inc

26 Jun 26 15:59
LAST:

9.970

CHANGE:
 0.04		OPEN:
9.910		HIGH:
10.185		ASK:
4.360		VOLUME:
5.37M
CHG(%):
0.40		PREV:
9.900		LOW:
9.661		BID:
10.120		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
26 Jun 269.91010.1859.6619.94010.99M
25 Jun 2610.00010.9409.6959.90019.06M
24 Jun 269.42010.0109.39010.0008.52M
23 Jun 269.1809.5009.1009.3105.14M
22 Jun 269.0409.3358.9109.1407.41M
18 Jun 269.1009.5408.9808.9908.88M
17 Jun 268.9509.1808.8208.9504.45M
16 Jun 269.0909.1808.7958.9203.58M
15 Jun 268.7609.0808.7059.0604.15M
12 Jun 268.4708.7358.4508.7002.39M

PROFILE

Name:Biocryst Pharma Inc
About:BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in phase 1; Avoralstat, an ocular plasma kallikrein inhibitor for diabetic macular edema that is in preclinical phase; and BCX10013, an oral Factor D inhibitor for complement-mediated diseases, as well as developing Oral C5 Inhibitor and Oral C2 Inhibitor. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Shionogi & Co., Ltd., Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Sector:Healthcare
Address:4505 Emperor Boulevard, Durham, NC, United States, 27703
Website:https://www.biocryst.com
CUSIP:09058V103
CIK:0000882796
ISIN:US09058V1035
FIGI:BBG000BLYWX6
LEI:549300Z0INP1Z5NP6J59

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:7.83 
Forward P/E:11.82 
PEG Ratio:0.12 
Price to Sales:2.76 
Price to Book:-16.96 
Profit Margin:-0.06 
Operating Margin:0.18 
Return on Assets:0.07 
Return on Equity:0.19 
EPS Ratio:1.21 
Revenue:557.51M 
EBITDA:13.45M 
Shares:250.8M 
Market Cap:2.50B 

TECHNICAL INDICATORS

MA5:9.663.2%
MA10:9.297.3%
MA20:8.8712.5%
MA50:8.9211.8%
MA100:8.6814.9%
MA200:7.9725.1%
STO9:50.50
STO14:63.64
RSI14:80.72 
WPR14:-3.31 
MTM14:1.51
ROC14:0.18 
ATR:0.47 
Week High:10.949.7%
Week Low:8.9111.9%
Month High:10.949.7%
Month Low:8.0625.1%
Year High:10.949.7%
Year Low:6.0066.2%
Volatility:44.41 

RECENT DIVIDENDS

Date Amount
11 Jun 2014$0.00
05 Jun 2014$0.00
20 May 2014$0.00
16 May 2014$0.00
02 Apr 2014$0.00